Daiichi-Sankyo Passion for Innovation. Compassion for Patients.™

  • Location Finder
  • Product Finder
  • Career Finder
  • About us
    • Who We Are

      Global Vision/Mission

      Company Culture

      Business Strategy

      Mid-term Plan

      History

    • Responsibility

      CSR (Corporate Social Responsibility)

      Business Conduct

      Corporate Philanthropy

      Healthy Living

    • Our People

      Global HR Messages

    • Partnerships

      Business Development

    • Company Profile

      Company information

      Corporate Management Information

      Company Governance

      Global Structure

    • Daiichi Sankyo Library
  • R&D
    • Our Approach

      Vision/Overview

      R&D Organization

      About Clinical Studies

    • Pipeline

      Pipeline (tool)

      Late-stage Products

  • Media & Investors
    • Media Relations

      Press Releases

    • Investor Relations

      Annual Reports

      IR Calendar

      Quarterly Results

      Financial Highlights

      IR Document Library

      Information for Shareholders

      Tokyo Stock Exchange

  • CSR
  • Daiichi Sankyo Liblary
  • e-healthy recipe
  • 前へ
  • 次へ

Featured Stories

Who We Are

Who We Are

Daiichi Sankyo is a global pharmaceutical company with its corporate origin in Japan.

read more ...

Investor Relations

Investor Relations

Top management presentation and related reference materials for Daiichi Sankyo’s fiscal year 2012 (April 1, 2012, to March 31, 2013) business results

read more ...

Featured News

  Date
Description  
Topic 2013.05.22 Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives PDF
Topic 2013.05.14 RANBAXY ANNOUNCES CONCLUSION OF PREVIOUSLY DISCLOSED INVESTIGATION BY U.S. DEPARTMENT OF JUSTICE PDF
Topic 2013.05.13 Differences Between Consolidated Forecasts and Consolidated Results for the Fiscal Year Ended March 31, 2013 PDF
Topic 2013.05.13 Daiichi Sankyo Announces New Executive Candidate PDF
Topic 2013.05.09 Ranbaxy Q1 CY 2013 Sales Rs.24,398 Mn. Base business grows by over 10%; Focus continues in branded markets and differentiated products PDF

Trademark-infringing product, "Glutax 4G Premium,"
found on sale online in Malaysia and Indonesia

Site map


About us


Who We Are

Responsibility

Our People

Partnerships

Company Profile

Daiichi Sankyo Library

R&D


Our Approach

Pipeline

Media & Investors


Media Relations

Investor Relations


  • Terms and Conditions
  • Contacts
  • Site Map
  • Handling of personal information on this website

Copyright© DAIICHI SANKYO COMPANY, LIMITED. All Rights Reserved.